{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:17:22Z","timestamp":1788135442403,"version":"build-2803163510"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"vor","delay-in-days":91,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U24A20767"],"award-info":[{"award-number":["U24A20767"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273625"],"award-info":[{"award-number":["82273625"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82504403"],"award-info":[{"award-number":["82504403"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["821038388"],"award-info":[{"award-number":["821038388"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LRG25H260001"],"award-info":[{"award-number":["LRG25H260001"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LQN26H260001"],"award-info":[{"award-number":["LQN26H260001"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LQN26H260002"],"award-info":[{"award-number":["LQN26H260002"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004863","name":"Zhejiang Chinese Medical University","doi-asserted-by":"publisher","award":["2023RCZXZK09"],"award-info":[{"award-number":["2023RCZXZK09"]}],"id":[{"id":"10.13039\/501100004863","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004863","name":"Zhejiang Chinese Medical University","doi-asserted-by":"publisher","award":["2024RCZXZK12"],"award-info":[{"award-number":["2024RCZXZK12"]}],"id":[{"id":"10.13039\/501100004863","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2024M762958"],"award-info":[{"award-number":["2024M762958"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"DOI":"10.1038\/s42003-026-10398-3","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T08:06:19Z","timestamp":1780301179000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hepatic Hamp restoration contributes to nicotinamide mononucleotide (NMN)-alleviated hepatic steatosis in chronic alcohol-fed mice"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2093-2767","authenticated-orcid":false,"given":"Feiwei","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxuan","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiwen","family":"Pi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingling","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liuhua","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rucheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinchao","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9262-9513","authenticated-orcid":false,"given":"Qing","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9912-7439","authenticated-orcid":false,"given":"Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2926-673X","authenticated-orcid":false,"given":"Songtao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,1]]},"reference":[{"key":"10398_CR1","unstructured":"World Health Organization. Global status report on alcohol and health and treatment of substance use disorders. https:\/\/www.who.int\/publications\/i\/item\/9789240096745 (2024)."},{"key":"10398_CR2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI176345","volume":"134","author":"B Mackowiak","year":"2024","unstructured":"Mackowiak, B., Fu, Y., Maccioni, L. & Gao, B. Alcohol-associated liver disease. J. Clin. Invest. 134, e176345 (2024).","journal-title":"J. Clin. Invest."},{"key":"10398_CR3","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.redox.2017.02.011","volume":"12","author":"R Jokinen","year":"2017","unstructured":"Jokinen, R., Pirnes-Karhu, S., Pietil\u00e4inen, K. H. & Pirinen, E. Adipose tissue NAD+-homeostasis, sirtuins and poly(ADP-ribose) polymerases -important players in mitochondrial metabolism and metabolic health. Redox Biol. 12, 246\u2013263 (2017).","journal-title":"Redox Biol."},{"key":"10398_CR4","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1056\/NEJMra2207599","volume":"387","author":"R Bataller","year":"2022","unstructured":"Bataller, R., Arab, J. P. & Shah, V. H. Alcohol-associated hepatitis. N. Engl. J. Med. 387, 2436\u20132448 (2022).","journal-title":"N. Engl. J. Med."},{"key":"10398_CR5","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41572-018-0014-7","volume":"4","author":"HK Seitz","year":"2018","unstructured":"Seitz, H. K. et al. Alcoholic liver disease. Nat. Rev. Dis. Prim. 4, 16 (2018).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10398_CR6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s42255-019-0161-5","volume":"2","author":"E Katsyuba","year":"2020","unstructured":"Katsyuba, E., Romani, M., Hofer, D. & Auwerx, J. NAD+ homeostasis in health and disease. Nat. Metab. 2, 9\u201331 (2020).","journal-title":"Nat. Metab."},{"key":"10398_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70086","volume":"6","author":"NM Gold","year":"2025","unstructured":"Gold, N. M. et al. Therapeutic potential of nicotinamide and ABT263 in alcohol-associated liver disease through targeting cellular senescence. MedComm 6, e70086 (2025).","journal-title":"MedComm"},{"key":"10398_CR8","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.jhep.2020.04.038","volume":"73","author":"Q Song","year":"2020","unstructured":"Song, Q. et al. ER stress-induced upregulation of NNMT contributes to alcohol-related fatty liver development. J. Hepatol. 73, 783\u2013793 (2020).","journal-title":"J. Hepatol."},{"key":"10398_CR9","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1146\/annurev-pathmechdis-031521-030435","volume":"18","author":"X Wu","year":"2023","unstructured":"Wu, X. et al. Recent advances in understanding of pathogenesis of alcohol-associated liver disease. Annu Rev. Pathol. 18, 411\u2013438 (2023).","journal-title":"Annu Rev. Pathol."},{"key":"10398_CR10","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adt6195","volume":"11","author":"Q Ding","year":"2025","unstructured":"Ding, Q. et al. Hepatic NMNAT1 is required to defend against alcohol-associated fatty liver disease. Sci. Adv. 11, eadt6195 (2025).","journal-title":"Sci. Adv."},{"key":"10398_CR11","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1016\/j.jnutbio.2012.12.012","volume":"24","author":"X Dou","year":"2013","unstructured":"Dou, X. et al. Protection of nicotinic acid against oxidative stress-induced cell death in hepatocytes contributes to its beneficial effect on alcohol-induced liver injury in mice. J. Nutr. Biochem. 24, 1520\u20131528 (2013).","journal-title":"J. Nutr. Biochem."},{"key":"10398_CR12","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.freeradbiomed.2025.05.415","volume":"236","author":"Q Pu","year":"2025","unstructured":"Pu, Q. et al. Tetramethylpyrazine: a fermented alcohol product that mitigates alcoholic liver disease in mice. Free Radic. Biol. Med. 236, 160\u2013175 (2025).","journal-title":"Free Radic. Biol. Med."},{"key":"10398_CR13","doi-asserted-by":"publisher","first-page":"e0212523","DOI":"10.1371\/journal.pone.0212523","volume":"14","author":"X Xiong","year":"2019","unstructured":"Xiong, X. et al. NAMPT overexpression alleviates alcohol-induced hepatic steatosis in mice. PLoS ONE 14, e0212523 (2019).","journal-title":"PLoS ONE"},{"key":"10398_CR14","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.jhep.2016.10.023","volume":"66","author":"P Mukhopadhyay","year":"2017","unstructured":"Mukhopadhyay, P. et al. PARP inhibition protects against alcoholic and non-alcoholic steatohepatitis. J. Hepatol. 66, 589\u2013600 (2017).","journal-title":"J. Hepatol."},{"key":"10398_CR15","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.3389\/fphys.2019.01042","volume":"10","author":"Y Ma","year":"2019","unstructured":"Ma, Y. et al. Hepatic SIRT3 upregulation in response to chronic alcohol consumption contributes to alcoholic liver disease in mice. Front. Physiol. 10, 1042 (2019).","journal-title":"Front. Physiol."},{"key":"10398_CR16","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1002\/hep.29229","volume":"66","author":"S Li","year":"2017","unstructured":"Li, S. et al. Sirtuin 3 acts as a negative regulator of autophagy dictating hepatocyte susceptibility to lipotoxicity. Hepatology 66, 936\u2013952 (2017).","journal-title":"Hepatology"},{"key":"10398_CR17","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1002\/hep.29242","volume":"66","author":"W Li","year":"2017","unstructured":"Li, W. et al. Alcohol abstinence ameliorates the dysregulated immune profiles in patients with alcoholic hepatitis: a prospective observational study. Hepatology 66, 575\u2013590 (2017).","journal-title":"Hepatology"},{"key":"10398_CR18","doi-asserted-by":"publisher","first-page":"101117","DOI":"10.1016\/j.plipres.2021.101117","volume":"84","author":"M Sz\u00e1nt\u00f3","year":"2021","unstructured":"Sz\u00e1nt\u00f3, M., Gupte, R., Kraus, W. L., Pacher, P. & Bai, P. PARPs in lipid metabolism and related diseases. Prog. Lipid Res. 84, 101117 (2021).","journal-title":"Prog. Lipid Res."},{"key":"10398_CR19","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1016\/j.jhep.2020.11.025","volume":"74","author":"Q Ding","year":"2021","unstructured":"Ding, Q., Ma, Y., Lai, S., Dou, X. & Li, S. NNMT aggravates hepatic steatosis, but alleviates liver injury in alcoholic liver disease. J. Hepatol. 74, 1248\u20131250 (2021).","journal-title":"J. Hepatol."},{"key":"10398_CR20","doi-asserted-by":"publisher","first-page":"16370","DOI":"10.1021\/acs.jafc.5c01450","volume":"73","author":"Q Ding","year":"2025","unstructured":"Ding, Q. et al. SMPD3 inhibition contributes to nicotinamide-ameliorated hepatic steatosis in chronic alcohol-fed mice. J. Agric. Food Chem. 73, 16370\u201316383 (2025).","journal-title":"J. Agric. Food Chem."},{"key":"10398_CR21","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.redox.2018.04.006","volume":"17","author":"S Wang","year":"2018","unstructured":"Wang, S. et al. Nicotinamide riboside attenuates alcohol induced liver injuries via activation of SirT1\/PGC-1\u03b1\/mitochondrial biosynthesis pathway. Redox Biol. 17, 89\u201398 (2018).","journal-title":"Redox Biol."},{"key":"10398_CR22","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.cmet.2017.11.002","volume":"27","author":"J Yoshino","year":"2018","unstructured":"Yoshino, J., Baur, J. A. & Imai, S.-I. NAD+ intermediates: the biology and therapeutic potential of NMN and NR. Cell Metab. 27, 513\u2013528 (2018).","journal-title":"Cell Metab."},{"key":"10398_CR23","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s40246-019-0251-1","volume":"13","author":"MA Assiri","year":"2019","unstructured":"Assiri, M. A. et al. Investigating RNA expression profiles altered by nicotinamide mononucleotide therapy in a chronic model of alcoholic liver disease. Hum. Genom. 13, 65 (2019).","journal-title":"Hum. Genom."},{"key":"10398_CR24","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.ajpath.2011.11.017","volume":"180","author":"W Zhong","year":"2012","unstructured":"Zhong, W. et al. Chronic alcohol exposure stimulates adipose tissue lipolysis in mice: role of reverse triglyceride transport in the pathogenesis of alcoholic steatosis. Am. J. Pathol. 180, 998\u20131007 (2012).","journal-title":"Am. J. Pathol."},{"key":"10398_CR25","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1002\/hep.32675","volume":"77","author":"M Mathur","year":"2023","unstructured":"Mathur, M. et al. Adipose lipolysis is important for ethanol to induce fatty liver in the National Institute on Alcohol Abuse and Alcoholism murine model of chronic and binge ethanol feeding. Hepatology 77, 1688\u20131701 (2023).","journal-title":"Hepatology"},{"key":"10398_CR26","doi-asserted-by":"publisher","DOI":"10.1097\/HC9.0000000000000641","volume":"9","author":"N Huda","year":"2025","unstructured":"Huda, N. et al. Silencing FAF2 mitigates alcohol-induced hepatic steatosis by modulating lipolysis and PCSK9 pathway. Hepatol. Commun. 9, e0641 (2025).","journal-title":"Hepatol. Commun."},{"key":"10398_CR27","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1002\/hep.21895","volume":"46","author":"DD Harrison-Findik","year":"2007","unstructured":"Harrison-Findik, D. D. et al. Iron-mediated regulation of liver hepcidin expression in rats and mice is abolished by alcohol. Hepatology 46, 1979\u20131985 (2007).","journal-title":"Hepatology"},{"key":"10398_CR28","doi-asserted-by":"publisher","first-page":"4925","DOI":"10.3748\/wjg.v13.i37.4925","volume":"13","author":"DD Harrison-Findik","year":"2007","unstructured":"Harrison-Findik, D. D. Role of alcohol in the regulation of iron metabolism. World J. Gastroenterol. 13, 4925\u20134930 (2007).","journal-title":"World J. Gastroenterol."},{"key":"10398_CR29","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1126\/science.1104742","volume":"306","author":"E Nemeth","year":"2004","unstructured":"Nemeth, E. et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306, 2090\u20132093 (2004).","journal-title":"Science"},{"key":"10398_CR30","doi-asserted-by":"publisher","first-page":"4292","DOI":"10.1182\/blood-2008-02-139915","volume":"112","author":"T Ganz","year":"2008","unstructured":"Ganz, T., Olbina, G., Girelli, D., Nemeth, E. & Westerman, M. Immunoassay for human serum hepcidin. Blood 112, 4292\u20134297 (2008).","journal-title":"Blood"},{"key":"10398_CR31","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1182\/blood-2003-03-0672","volume":"102","author":"T Ganz","year":"2003","unstructured":"Ganz, T. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood 102, 783\u2013788 (2003).","journal-title":"Blood"},{"key":"10398_CR32","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.jare.2021.08.003","volume":"37","author":"H Nadeeshani","year":"2022","unstructured":"Nadeeshani, H., Li, J., Ying, T., Zhang, B. & Lu, J. Nicotinamide mononucleotide (NMN) as an anti-aging health product \u2013 promises and safety concerns. J. Adv. Res. 37, 267\u2013278 (2022).","journal-title":"J. Adv. Res."},{"key":"10398_CR33","doi-asserted-by":"publisher","first-page":"4068","DOI":"10.1128\/MCB.00723-12","volume":"32","author":"ER Anderson","year":"2012","unstructured":"Anderson, E. R. et al. The hypoxia-inducible factor\u2013C\/EBP\u03b1 axis controls ethanol-mediated hepcidin repression. Mol. Cell. Biol. 32, 4068\u20134077 (2012).","journal-title":"Mol. Cell. Biol."},{"key":"10398_CR34","doi-asserted-by":"publisher","first-page":"41163","DOI":"10.1074\/jbc.M202653200","volume":"277","author":"B Courselaud","year":"2002","unstructured":"Courselaud, B. et al. C\/EBPalpha regulates hepatic transcription of hepcidin, an antimicrobial peptide and regulator of iron metabolism. Cross-talk between C\/EBP pathway and iron metabolism. J. Biol. Chem. 277, 41163\u201341170 (2002).","journal-title":"J. Biol. Chem."},{"key":"10398_CR35","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/s41392-020-00311-7","volume":"5","author":"N Xie","year":"2020","unstructured":"Xie, N. et al. NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential. Signal Transduct. Target. Ther. 5, 227 (2020).","journal-title":"Signal Transduct. Target. Ther."},{"key":"10398_CR36","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1016\/j.advnut.2023.08.008","volume":"14","author":"Q Song","year":"2023","unstructured":"Song, Q. et al. The safety and antiaging effects of nicotinamide mononucleotide in human clinical trials: an update. Adv. Nutr. 14, 1416\u20131435 (2023).","journal-title":"Adv. Nutr."},{"key":"10398_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-18272-y","volume":"12","author":"Y Fukamizu","year":"2022","unstructured":"Fukamizu, Y. et al. Safety evaluation of \u03b2-nicotinamide mononucleotide oral administration in healthy adult men and women. Sci. Rep. 12, 14442 (2022).","journal-title":"Sci. Rep."},{"key":"10398_CR38","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.cmet.2016.09.013","volume":"24","author":"KF Mills","year":"2016","unstructured":"Mills, K. F. et al. Long-term administration of nicotinamide mononucleotide mitigates age-associated physiological decline in mice. Cell Metab. 24, 795\u2013806 (2016).","journal-title":"Cell Metab."},{"key":"10398_CR39","doi-asserted-by":"publisher","first-page":"149590","DOI":"10.1016\/j.bbrc.2024.149590","volume":"702","author":"T Iqbal","year":"2024","unstructured":"Iqbal, T. & Nakagawa, T. The therapeutic perspective of NAD+ precursors in age-related diseases. Biochem. Biophys. Res. Commun. 702, 149590 (2024).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10398_CR40","doi-asserted-by":"publisher","first-page":"9737","DOI":"10.1007\/s11033-022-07459-1","volume":"49","author":"M Soma","year":"2022","unstructured":"Soma, M. & Lalam, S. K. The role of nicotinamide mononucleotide (NMN) in anti-aging, longevity, and its potential for treating chronic conditions. Mol. Biol. Rep. 49, 9737\u20139748 (2022).","journal-title":"Mol. Biol. Rep."},{"key":"10398_CR41","doi-asserted-by":"publisher","first-page":"3199","DOI":"10.1039\/D3FO05221D","volume":"15","author":"Y Gu","year":"2024","unstructured":"Gu, Y. et al. -nicotinamide mononucleotide supplementation prolongs the lifespan of prematurely aged mice and protects colon function in ageing mice. Food Funct. 15, 3199\u20133213 (2024).","journal-title":"Food Funct."},{"key":"10398_CR42","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.cmet.2011.08.014","volume":"14","author":"J Yoshino","year":"2011","unstructured":"Yoshino, J., Mills, K. F., Yoon, M. J. & Imai, S. Nicotinamide mononucleotide, a key NAD(+) intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice. Cell Metab. 14, 528\u2013536 (2011).","journal-title":"Cell Metab."},{"key":"10398_CR43","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1126\/science.abe9985","volume":"372","author":"M Yoshino","year":"2021","unstructured":"Yoshino, M. et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science 372, 1224\u20131229 (2021).","journal-title":"Science"},{"key":"10398_CR44","doi-asserted-by":"publisher","first-page":"116701","DOI":"10.1016\/j.biopha.2024.116701","volume":"175","author":"J Zhang","year":"2024","unstructured":"Zhang, J. & Chen, F. Integrated transcriptome and metabolome study reveal the therapeutic effects of nicotinamide riboside and nicotinamide mononucleotide on nonalcoholic fatty liver disease. Biomed. Pharmacother. 175, 116701 (2024).","journal-title":"Biomed. Pharmacother."},{"key":"10398_CR45","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1111\/acer.12396","volume":"38","author":"Q Li","year":"2014","unstructured":"Li, Q. et al. Dietary nicotinic acid supplementation ameliorates chronic alcohol-induced fatty liver in rats. Alcohol. Clin. Exp. Res. 38, 1982\u20131992 (2014).","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10398_CR46","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1194\/jlr.R119000547","volume":"61","author":"S Jeon","year":"2020","unstructured":"Jeon, S. & Carr, R. Alcohol effects on hepatic lipid metabolism. J. Lipid Res. 61, 470\u2013479 (2020).","journal-title":"J. Lipid Res."},{"key":"10398_CR47","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1194\/jlr.M041863","volume":"55","author":"RD Clugston","year":"2014","unstructured":"Clugston, R. D. et al. CD36-deficient mice are resistant to alcohol- and high-carbohydrate-induced hepatic steatosis. J. Lipid Res. 55, 239\u2013246 (2014).","journal-title":"J. Lipid Res."},{"key":"10398_CR48","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1002\/hep.26912","volume":"59","author":"Z Wang","year":"2014","unstructured":"Wang, Z. et al. Nuclear factor (erythroid-derived 2)-like 2 activation-induced hepatic very-low-density lipoprotein receptor overexpression in response to oxidative stress contributes to alcoholic liver disease in mice. Hepatology 59, 1381\u20131392 (2014).","journal-title":"Hepatology"},{"key":"10398_CR49","first-page":"1662","volume":"1861","author":"MA Lounis","year":"2016","unstructured":"Lounis, M. A. et al. SCD1 deficiency protects mice against ethanol-induced liver injury. Biochim. Biophys. Acta (BBA) Mol. Cell Biol. Lipids 1861, 1662\u20131670 (2016).","journal-title":"Biochim. Biophys. Acta (BBA) Mol. Cell Biol. Lipids"},{"key":"10398_CR50","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.freeradbiomed.2021.08.005","volume":"174","author":"R Yue","year":"2021","unstructured":"Yue, R. et al. Activation of PPAR\u03b1-catalase pathway reverses alcoholic liver injury via upregulating NAD synthesis and accelerating alcohol clearance. Free Radic. Biol. Med. 174, 249\u2013263 (2021).","journal-title":"Free Radic. Biol. Med."},{"key":"10398_CR51","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1021\/acs.jproteome.3c00093","volume":"22","author":"T Zhang","year":"2023","unstructured":"Zhang, T. et al. Metabolomics reveals gut microbiota contribute to PPAR\u03b1 deficiency-induced alcoholic liver injury. J. Proteome Res. 22, 2327\u20132338 (2023).","journal-title":"J. Proteome Res."},{"key":"10398_CR52","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.jhep.2006.05.009","volume":"45","author":"C Ji","year":"2006","unstructured":"Ji, C., Chan, C. & Kaplowitz, N. Predominant role of sterol response element binding proteins (SREBP) lipogenic pathways in hepatic steatosis in the murine intragastric ethanol feeding model. J. Hepatol. 45, 717\u2013724 (2006).","journal-title":"J. Hepatol."},{"key":"10398_CR53","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1038\/s41575-023-00822-y","volume":"20","author":"LA D\u00edaz","year":"2023","unstructured":"D\u00edaz, L. A., Arab, J. P., Louvet, A., Bataller, R. & Arrese, M. The intersection between alcohol-related liver disease and nonalcoholic fatty liver disease. Nat. Rev. Gastroenterol. Hepatol. 20, 764\u2013783 (2023).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10398_CR54","doi-asserted-by":"publisher","first-page":"6493","DOI":"10.3390\/ijms22126493","volume":"22","author":"E Nemeth","year":"2021","unstructured":"Nemeth, E. & Ganz, T. Hepcidin-ferroportin interaction controls systemic iron homeostasis. Int. J. Mol. Sci. 22, 6493 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"10398_CR55","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1146\/annurev-med-043021-032816","volume":"74","author":"E Nemeth","year":"2023","unstructured":"Nemeth, E. & Ganz, T. Hepcidin and iron in health and disease. Annu. Rev. Med. 74, 261\u2013277 (2023).","journal-title":"Annu. Rev. Med."},{"key":"10398_CR56","doi-asserted-by":"publisher","first-page":"e65551","DOI":"10.1371\/journal.pone.0065551","volume":"8","author":"D Lin","year":"2013","unstructured":"Lin, D. et al. Decreased serum hepcidin concentration correlates with brain iron deposition in patients with HBV-related cirrhosis. PLoS ONE 8, e65551 (2013).","journal-title":"PLoS ONE"},{"key":"10398_CR57","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1002\/hep.30486","volume":"69","author":"I Spivak","year":"2019","unstructured":"Spivak, I. et al. Low serum hepcidin is associated with reduced short-term survival in adults with acute liver failure. Hepatology 69, 2136\u20132149 (2019).","journal-title":"Hepatology"},{"key":"10398_CR58","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.ebiom.2018.07.024","volume":"34","author":"N Lee","year":"2018","unstructured":"Lee, N. et al. Decreased hepcidin levels are associated with low steady-state hemoglobin in children with sickle cell disease in Tanzania. eBioMedicine 34, 158\u2013164 (2018).","journal-title":"eBioMedicine"},{"key":"10398_CR59","first-page":"179","volume":"42","author":"D Vela","year":"2018","unstructured":"Vela, D., Sopi, R. B. & Mladenov, M. Low hepcidin in type 2 diabetes mellitus: Examining the molecular links and their clinical implications. Can. J. Diab. 42, 179\u2013187 (2018).","journal-title":"Can. J. Diab."},{"key":"10398_CR60","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1515\/cclm-2023-0540","volume":"62","author":"R Sharma","year":"2024","unstructured":"Sharma, R., Zhao, W., Zafar, Y., Murali, A. R. & Brown, K. E. Serum hepcidin levels in chronic liver disease: a systematic review and meta-analysis. Clin. Chem. Lab. Med. 62, 373\u2013384 (2024).","journal-title":"Clin. Chem. Lab. Med."},{"key":"10398_CR61","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1097\/MEG.0b013e328355cfd0","volume":"24","author":"L Costa-Matos","year":"2012","unstructured":"Costa-Matos, L. et al. Liver hepcidin mRNA expression is inappropriately low in alcoholic patients compared with healthy controls. Eur. J. Gastroenterol. Hepatol. 24, 1158\u20131165 (2012).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10398_CR62","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/j.ajpath.2021.04.005","volume":"191","author":"SA Bloomer","year":"2021","unstructured":"Bloomer, S. A. & Brown, K. E. Hepcidin and iron metabolism in experimental liver injury. Am. J. Pathol. 191, 1165\u20131179 (2021).","journal-title":"Am. J. Pathol."},{"key":"10398_CR63","doi-asserted-by":"publisher","first-page":"92","DOI":"10.2478\/jtim-2021-0056","volume":"10","author":"S Mueller","year":"2022","unstructured":"Mueller, S., Chen, C., Mueller, J. & Wang, S. Novel insights into alcoholic liver disease: iron overload, iron sensing and hemolysis. J. Transl. Intern. Med. 10, 92\u2013124 (2022).","journal-title":"J. Transl. Intern. Med."},{"key":"10398_CR64","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s00018-022-04239-9","volume":"79","author":"L-X Li","year":"2022","unstructured":"Li, L.-X., Guo, F.-F., Liu, H. & Zeng, T. Iron overload in alcoholic liver disease: underlying mechanisms, detrimental effects, and potential therapeutic targets. Cell. Mol. Life Sci. 79, 201 (2022).","journal-title":"Cell. Mol. Life Sci."},{"key":"10398_CR65","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1002\/hep4.1083","volume":"1","author":"T Koppe","year":"2017","unstructured":"Koppe, T. et al. Nicotinamide N-methyltransferase expression decreases in iron overload, exacerbating toxicity in mouse hepatocytes. Hepatol. Commun. 1, 803\u2013815 (2017).","journal-title":"Hepatol. Commun."},{"key":"10398_CR66","doi-asserted-by":"publisher","DOI":"10.1097\/HC9.0000000000000604","volume":"9","author":"C Li","year":"2025","unstructured":"Li, C. et al. Hepcidin inhibits hepatocyte apoptosis through the PERK pathway in acute liver injury and fibrosis. Hepatol. Commun. 9, e0604 (2025).","journal-title":"Hepatol. Commun."},{"key":"10398_CR67","doi-asserted-by":"publisher","DOI":"10.1172\/JCI189607","volume":"135","author":"Y Pan","year":"2025","unstructured":"Pan, Y. et al. Hepcidin sustains kupffer cell immune defense against bloodstream bacterial infection via gut-derived metabolites in mice. J. Clin. Invest. 135, e189607 (2025).","journal-title":"J. Clin. Invest."},{"key":"10398_CR68","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/s41575-018-0099-1","volume":"16","author":"JS Bajaj","year":"2019","unstructured":"Bajaj, J. S. Alcohol, liver disease and the gut microbiota. Nat. Rev. Gastroenterol. Hepatol. 16, 235\u2013246 (2019).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10398_CR69","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1016\/j.ajpath.2022.08.010","volume":"193","author":"N Ali","year":"2023","unstructured":"Ali, N., Ferrao, K. & Mehta, K. J. Liver iron loading in alcohol-associated liver disease. Am. J. Pathol. 193, 1427\u20131439 (2023).","journal-title":"Am. J. Pathol."},{"key":"10398_CR70","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1053\/j.gastro.2008.01.016","volume":"134","author":"N Horiguchi","year":"2008","unstructured":"Horiguchi, N. et al. Cell type-dependent pro- and anti-inflammatory role of signal transducer and activator of transcription 3 in alcoholic liver injury. Gastroenterology 134, 1148\u20131158 (2008).","journal-title":"Gastroenterology"},{"key":"10398_CR71","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1002\/hep.22470","volume":"48","author":"I Hritz","year":"2008","unstructured":"Hritz, I. et al. The critical role of toll-like receptor (TLR) 4 in alcoholic liver disease is independent of the common TLR adapter MyD88. Hepatology 48, 1224\u20131231 (2008).","journal-title":"Hepatology"},{"key":"10398_CR72","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1097\/00007890-199306000-00011","volume":"55","author":"S Suzuki","year":"1993","unstructured":"Suzuki, S., Toledo-Pereyra, L. H., Rodriguez, F. J. & Cejalvo, D. Neutrophil infiltration as an important factor in liver ischemia and reperfusion injury. Modulating effects of FK506 and cyclosporine. Transplantation 55, 1265\u20131272 (1993).","journal-title":"Transplantation"}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10398-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10398-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10398-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:02:29Z","timestamp":1788134549000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10398-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["10398"],"URL":"https:\/\/doi.org\/10.1038\/s42003-026-10398-3","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,1]]},"assertion":[{"value":"17 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"1154"}}